sunanda-kane-14962535 (1)Sherman Prize Honors Excellence in Crohn’s and Colitis

by Sunanda V. Kane, MD, FACG

This week, the recipients of the inaugural Sherman Prize were announced. As a member of the Prize Selection Committee, I am proud to share this news with my ACG colleagues and to honor researchers advancing care for our patients with IBD.

About the Sherman Prize: “The first prize of its kind to honor exceptional and pioneering achievements in Crohn’s disease and ulcerative colitis, recognizing outstanding contributions by health care professionals, medical researchers, public health advocates, and educators who are advancing patient care, medical research, and public service in the field of inflammatory bowel disease (IBD).”

Two Sherman Prizes of $100,000 are awarded each year to individuals who have made extraordinary contributions to caring for patients or advocating on their behalf, advancing medical research, and/or providing public education. The program also awards a $25,000 Sherman Emerging Leader Prize to an individual who demonstrates high potential in the field of Crohn’s and colitis.

You can learn more about the recipients, their research and the Sherman Prize at

szigethy_eva_67982Dr. Eva Szigethy: Shifting Treatment Paradigms and Improving Health Outcomes by Integrating Behavioral Health into the Comprehensive Care of IBD Patients

  • Eva Szigethy, MD, PhD, co-director of the UPMC Total Care-IBD Program and associate professor of psychiatry, medicine and pediatrics in the Department of Psychiatry at the University of Pittsburgh School of Medicine is awarded a Sherman Prize for her achievements in pioneering the integration of behavioral health into the comprehensive care of IBD patients to improve health outcomes.


jamesdlewismdupennDr. James D. Lewis: Optimizing IBD Therapy through Rigorous Clinical Study and Exploring Novel Treatment Strategies to Improve Outcomes with Less Toxicity

  • James D. Lewis, MD, MSCE, professor of medicine and epidemiology and associate director of the Inflammatory Bowel Disease Program at the University of Pennsylvania Perelman School of Medicine is recognized with a Sherman Prize for his 20-year career dedicated to optimizing IBD therapy and exploring novel treatment strategies through rigorous clinical study.


leanannchenmdNYUDr. Lea Ann Chen: An Emerging Physician-Scientist Studying IBD in Diverse Populations

  • Lea Ann Chen, MD, assistant professor of medicine, NYU School of Medicine and Attending Physician, NYC Health + Hospitals/Bellevue, is awarded the Sherman Emerging Leader Prize for her achievements as a physician-scientist studying IBD in diverse populations, with a focus on improving care for underserved communities.